重度OSA患者经TORS-OSA手术前后同型半胱氨酸水平变化
回顾性分析261例重度OSA患者接受经口机器人手术治疗前后多导睡眠图参数及血清同型半胱氨酸水平,术后同型半胱氨酸从12.1±3.9降至11.4±3.7 mcmol/L(差值-0.7±2.8 mcmol/L,p=.001),高同型半胱氨酸亚组下降更明显(差值-2.9±4.7 mcmol/L,p=.007),ΔODI与Δ同型半胱氨酸正相关(r=0.525,p=.012)。
要点
- 重度OSA患者TORS-OSA术后主要PSG参数显著改善。
- 术后同型半胱氨酸显著下降,高同型半胱氨酸亚组下降幅度更大。
- ΔODI与Δ同型半胱氨酸呈正相关(r=0.525,p=.012)。
核心结论
- TORS-OSA手术可降低OSA患者的同型半胱氨酸水平,术前同型半胱氨酸异常的重度OSA患者效果更明显。
研究设计与样本
- 回顾性病历审查,纳入261例重度OSA患者,比较手术前后多导睡眠图参数及血清同型半胱氨酸水平,采用配对t检验,并按术前同型半胱氨酸≥15 mcmol/L行亚组分析。
主要发现
- 术后主要PSG参数显著改善。
- 同型半胱氨酸从12.1±3.9降至11.4±3.7 mcmol/L(差值-0.7±2.8 mcmol/L,p=.001)。
- 高同型半胱氨酸亚组同型半胱氨酸下降更明显(差值-2.9±4.7 mcmol/L,p=.007)。
- ΔODI(氧减指数/h)与Δ同型半胱氨酸呈正相关(r=0.525,p=.012)。
关键数值与推荐
- 术前同型半胱氨酸≥15 mcmol/L定义为高同型半胱氨酸血症组。
- 术后同型半胱氨酸较术前下降0.7±2.8 mcmol/L(p=.001)。
- 高同型半胱氨酸血症组同型半胱氨酸下降2.9±4.7 mcmol/L(p=.007)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The increased risk of cardiovascular diseases owing to a high level of serum homocysteine has been widely reported. Literature has demonstrated that patients with obstructive sleep apnea/hypopnea syndrome (OSA) had a higher homocysteine level than control group. This study aimed to investigate the alteration of serum homocysteine levels in severe OSA patients receiving transoral robotic surgery (TORS). STUDY DESIGN: Retrospective chart review. SETTING: Tertiary academic medical center. METHODS: Data of polysomnography (PSG) and serum homocysteine levels before and at least 3 months after the surgery were collected and analyzed via paired t tests. A subgroup analysis based on the preoperative homocysteine level (≥15 mcmol/L, as hyperhomocysteinemia group) was conducted to compare the intergroup differences of homocysteine decrease. Pearson's correlation was used to survey the relationships between the changes of major PSG parameters and the levels of homocysteine decrease at baseline and after TORS-OSA surgery. RESULTS: Two hundred sixty-one patients with severe OSA were enrolled. There were significant improvements in major PSG parameters after TORS-OSA surgery. Homocysteine levels significantly decreased from 12.1 ± 3.9 to 11.4 ± 3.7 mcmol/L (difference = -0.7 ± 2.8 mcmol/L, p = .001) postoperatively, which was shown in the hyperhomocysteinemia group (difference = -2.9 ± 4.7 mcmol/L, p = .007) to a greater extent. Pearson's correlation revealed that ΔODI (oxygen desaturation index/h) was the predominant estimate with a positive association with Δhomocysteine (r = 0.525, p = .012). CONCLUSION: TORS-OSA surgery could decrease homocysteine levels in OSA patients. The effects were more relevant in severe OSA patients with abnormal preoperative homocysteine levels.
引用
- Chiu LW, Lin CW, Lin PW, et al. Homocysteine Levels in Severe OSA Patients Before and After TORS-OSA Surgery. Otolaryngol Head Neck Surg. 2023. PMID: 36939400. doi:10.1002/ohn.218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。